Vanda director Chrousos fails re-election, tenders resignation after majority withhold vote

Vanda Pharmaceuticals Inc.

Phaedra S. Chrousos received 20,071,828 for vs 22,780,322 against; less than majority of votes cast.
Chrousos resigned under company bylaws; Nominating/Governance Committee to decide acceptance.
Directors Polymeropoulos and Chrousos elected; Polymeropoulos got 33,976,239 for, 8,943,623 against.
Stockholders ratified PwC as auditor (44,750,588 for, 1,739,295 against) and approved say-on-pay.
Equity plan amendment passed (34,411,032 for, 8,565,705 against) to increase authorized shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.